Evusheld™ (tixagevimab/cilgavimab) – Emergency use authorization
December 8, 2021 - The FDA announced the emergency use authorization (EUA) approval of AstraZeneca’s Evusheld (tixagevimab/cilgavimab), for the pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and pediatric individuals (12 years of age and older weighing at least 40 kg).
Top